報價延遲最少15分鐘:2025/01/21 05:38 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
139.61 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-45.62/6.85
|
|
企業價值
966.67M
|
| 資產負債 |
|
每股賬面淨值
29.73
|
| 現金流量 |
|
現金流量率
0.05
|
| 損益表 |
|
收益
216.19M
|
|
每股收益
39.34
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 05:38 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products. |